This is a Validated Antibody Database (VAD) review about mouse Ikaros, based on 5 published articles (read how Labome selects the articles), using Ikaros antibody in all methods. It is aimed to help Labome visitors find the most suited Ikaros antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Ikaros synonym: 5832432G11Rik; Ikaros; LyF-1; Zfpn1a1; Znfn1a1; hlk-1; mKIAA4227

Abcam
domestic rabbit monoclonal (EPR13790)
  • immunohistochemistry; mouse; loading ...; fig s6c
Abcam Ikaros antibody (Abcam, ab191394) was used in immunohistochemistry on mouse samples (fig s6c). J Clin Invest (2018) ncbi
Active Motif
mouse monoclonal (2A9)
  • western blot; human
Active Motif Ikaros antibody (Active Motif, 39355) was used in western blot on human samples . Nucleic Acids Res (2012) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology Ikaros antibody (Cell Signaling Technology, 5443) was used in western blot on human samples (fig 7b). Sci Adv (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
  • western blot; mouse; 1:1000; fig s4
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Cell Signaling Technology Ikaros antibody (Cell Signaling Technology, 5443) was used in western blot on human samples at 1:1000 (fig 1) and in western blot on mouse samples at 1:1000 (fig s4). Nat Med (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s2
Cell Signaling Technology Ikaros antibody (Cell Signaling, 5443) was used in western blot on mouse samples (fig s2). Biol Open (2016) ncbi
Articles Reviewed
  1. Liu J, Hideshima T, Xing L, Wang S, Zhou W, Samur M, et al. ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment. Sci Adv. 2021;7: pubmed publisher
  2. Boutboul D, Kuehn H, Van de Wyngaert Z, Niemela J, Callebaut I, Stoddard J, et al. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency. J Clin Invest. 2018;128:3071-3087 pubmed publisher
  3. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed publisher
  4. Carofino B, Ayanga B, Tracey L, Brooke Bisschop T, Justice M. PRDM14 promotes RAG-dependent Notch1 driver mutations in mouse T-ALL. Biol Open. 2016;5:645-53 pubmed publisher
  5. Yeung F, Chung E, Guess M, Bell M, Leinwand L. Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res. 2012;40:7303-18 pubmed publisher